Lakshmanan Thiruneelakantapillai

LT is the Vice President of Bioanalytical Development at Orna, where he leads the BA and PK team. He works cross functionally across R&D with a focus on defining the company’s PCD strategy and analytical method development to support nonclinical studies and clinical analytics for our immune-oncology and rare disease programs.

With more than 17 years of experience in bioanalytics in the pre-clinical and clinical development of biologics, biosimilars, and peptide drugs, LT has worked in multiple therapeutic areas including oncology, autoimmune and neurological diseases. Prior to joining Orna, he led the analytical and bioanalytical sciences at Xilio Therapeutics, developing masked antibody and cytokine therapies for oncology.

LT received his PhD in Bio-organic Chemistry from the Indian Institute of Technology Madras, Chennai, India and spent three years as a postdoctoral fellow in Glycobiology at the Johns Hopkins Medical School. In his spare time, he enjoys traveling for wildlife and landscape photography. He is also fluent in Tamil, one of the oldest living classical languages, which has an unbroken literary tradition of more than two millennia!